What Dogwood Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 1 | 3 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 4,098,360 | 370,902,180 |
| Disposed | 0 | 0 |
| Net activity | +4,098,360 | +370,902,180 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sealbond Ltd | Director | Oct 26 | Grant / award · A | +4,098,360 | $1.22 | +$5M | 25,920,693 |
| Sealbond Ltd | Director | Nov 21 | Derivative Conversion · C | +2,842,638 | — | — | 2,842,638 |
| Sealbond Ltd | Director | Nov 21 | Derivative Conversion · C | +21,610,950 | — | — | 21,822,333 |
| Pridgen William | Director | Aug 21 | Open-market buy · P | +15,335 | $1.30 | +$20K | 52,045 |
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | Aug 17 | Open-market buy · P | +25,000 | $1.25 | +$31.2K | 57,461 |
| Whitley Richard James | Director | Dec 08 | Open-market sale · S | −1,800 | $0.26 | −$466 | 700 |
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | May 23 | Open-market buy · P | +7,500 | $4.52 | +$33.9K | 32,461 |
| Walsh Angela | SVP OF FINANCE | May 23 | Open-market buy · P | +2,000 | $4.58 | +$9.15K | 3,000 |
| Whitley Richard James | Director | May 18 | Open-market buy · P | +500 | $4.53 | +$2.26K | 2,500 |
| Pridgen William | Director | May 18 | Open-market buy · P | +241 | $4.50 | +$1.08K | 36,710 |
| Pridgen William | Director | May 17 | Open-market buy · P | +13,450 | $4.38 | +$58.9K | 36,469 |
| Pridgen William | Director | Mar 29 | Open-market buy · P | +600 | $4.94 | +$2.96K | 23,019 |
| Pridgen William | Director | Mar 23 | Open-market buy · P | +2,197 | $5.46 | +$12K | 22,419 |
| Pridgen William | Director | Jan 27 | Open-market buy · P | +4,180 | $5.98 | +$25K | 18,722 |
| De La Rosa Abel | Director | Jan 07 | Open-market buy · P | +4,000 | $5.90 | +$23.6K | 4,000 |
| Whitley Richard James | Director | Jan 06 | Open-market buy · P | +1,800 | $5.72 | +$10.3K | 2,000 |
| Thomas John C | Director | Jan 04 | Open-market buy · P | +1,000 | $5.65 | +$5.65K | 1,000 |
| Keefer David R | Director | Jan 04 | Open-market buy · P | +5,000 | $5.80 | +$29K | 5,000 |
| Pridgen William | Director | Jan 03 | Open-market buy · P | +2,215 | $5.43 | +$12K | 14,542 |
| Whitley Richard James | Director | Dec 23 | Open-market buy · P | +200 | $5.73 | +$1.15K | 200 |
Loading...